Lexicon Pharmaceuticals Selects Medidata to Aid in Advancing Phase IIb Trial of Non-Opioid Drug for Neuropathic Pain

BrainSightAI Collaborate with Medidata and Dassault Systèmes

Lexicon will use Medidata’s decentralized clinical trial solutions to help advance in the Phase IIb LX9211 study to develop new treatments for diabetic peripheral neuropathy.